141 related articles for article (PubMed ID: 36951881)
21. Expression of CD1d and presence of invariant NKT cells in classical Hodgkin lymphoma.
Xu C; de Vries R; Visser L; Diepstra A; Gadola SD; Poppema S; van den Berg A
Am J Hematol; 2010 Jul; 85(7):539-41. PubMed ID: 20575029
[No Abstract] [Full Text] [Related]
22. A functional TNFRSF5 polymorphism and risk of non-Hodgkin lymphoma, a pooled analysis.
Nieters A; Bracci PM; de Sanjosé S; Becker N; Maynadié M; Benavente Y; Foretova L; Cocco P; Staines A; Holly EA; Boffetta P; Brennan P; Skibola CF
Int J Cancer; 2011 Mar; 128(6):1481-5. PubMed ID: 20473910
[TBL] [Abstract][Full Text] [Related]
23. Flow cytometry for non-Hodgkin and classical Hodgkin lymphoma.
Wu D; Wood BL; Fromm JR
Methods Mol Biol; 2013; 971():27-47. PubMed ID: 23296956
[TBL] [Abstract][Full Text] [Related]
24. Plasma cells in classical Hodgkin lymphoma: a new player in the microenvironment?
Visser L
Br J Haematol; 2019 Jan; 184(2):119-120. PubMed ID: 30485402
[No Abstract] [Full Text] [Related]
25. Human leukocyte antigens and genetic susceptibility to lymphoma.
McAulay KA; Jarrett RF
Tissue Antigens; 2015 Aug; 86(2):98-113. PubMed ID: 26189878
[TBL] [Abstract][Full Text] [Related]
26. Signal transducer and activator of transcription 6 is frequently activated in Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma.
Skinnider BF; Elia AJ; Gascoyne RD; Patterson B; Trumper L; Kapp U; Mak TW
Blood; 2002 Jan; 99(2):618-26. PubMed ID: 11781246
[TBL] [Abstract][Full Text] [Related]
27. Deep sequencing reveals lack of a clonal relationship between a metachronous classical hodgkin and diffuse large B-cell lymphoma.
Siddiqi IN; Ailawadhi S; Huang Q; Shibata RK; Kang H; Shibata D
Clin Lymphoma Myeloma Leuk; 2014 Jun; 14(3):e87-93. PubMed ID: 24548610
[No Abstract] [Full Text] [Related]
28. Nodular lymphocyte-predominant Hodgkin lymphoma.
Savage KJ; Mottok A; Fanale M
Semin Hematol; 2016 Jul; 53(3):190-202. PubMed ID: 27496311
[TBL] [Abstract][Full Text] [Related]
29. Diagnostic utility of STAT6
Van Slambrouck C; Huh J; Suh C; Song JY; Menon MP; Sohani AR; Duffield AS; Goldberg RC; Dama P; Kiyotani K; Godfrey J; Fitzpatrick C; Kline J; Smith SM; Jaffe ES; Hartmann S; Venkataraman G
Mod Pathol; 2020 May; 33(5):834-845. PubMed ID: 31822802
[TBL] [Abstract][Full Text] [Related]
30. Array-based DNA methylation analysis in classical Hodgkin lymphoma reveals new insights into the mechanisms underlying silencing of B cell-specific genes.
Ammerpohl O; Haake A; Pellissery S; Giefing M; Richter J; Balint B; Kulis M; Le J; Bibikova M; Drexler HG; Seifert M; Shaknovic R; Korn B; Küppers R; Martín-Subero JI; Siebert R
Leukemia; 2012 Jan; 26(1):185-8. PubMed ID: 21818115
[No Abstract] [Full Text] [Related]
31. Disparate survival and risk of secondary non-Hodgkin lymphoma in histologic subtypes of Hodgkin lymphoma: a population-based study.
Ali S; Olszewski AJ
Leuk Lymphoma; 2014 Jul; 55(7):1570-7. PubMed ID: 24067135
[TBL] [Abstract][Full Text] [Related]
32. Imaging for diagnosis, staging and response assessment of Hodgkin lymphoma and non-Hodgkin lymphoma.
McCarten KM; Nadel HR; Shulkin BL; Cho SY
Pediatr Radiol; 2019 Oct; 49(11):1545-1564. PubMed ID: 31620854
[TBL] [Abstract][Full Text] [Related]
33. [The molecular pathology of classical Hodgkin lymphoma].
Asano N
Rinsho Ketsueki; 2015 Oct; 56(10):2024-31. PubMed ID: 26458441
[TBL] [Abstract][Full Text] [Related]
34. [Hodgkin lymphomas ar negative with regard to bcl-2/JH gene rearrangement, but partly express BCL-2 protein: analysis of 83 cases from the German Hodgkin Trial].
Nolte M; Werner M; von Wasielewski R; Wilkens L; Fischer R; Hübner K; Georgii A
Verh Dtsch Ges Pathol; 1994; 78():329-33. PubMed ID: 7534007
[TBL] [Abstract][Full Text] [Related]
35. Cancer risks among relatives of children with Hodgkin and non-Hodgkin lymphoma.
Pang D; Alston RD; Eden TO; Birch JM
Int J Cancer; 2008 Sep; 123(6):1407-10. PubMed ID: 18561317
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of a panel of expert pathologists: review of the diagnosis and histological classification of Hodgkin and non-Hodgkin lymphomas in a population-based cancer registry.
Strobbe L; van der Schans SA; Heijker S; Meijer JW; Mattijssen EJ; Mandigers CM; de Kievit IM; Raemaekers JM; Hebeda KM; van Krieken JH
Leuk Lymphoma; 2014 May; 55(5):1018-22. PubMed ID: 23885798
[TBL] [Abstract][Full Text] [Related]
37. New concepts on histopathology of Hodgkin's disease.
Georgii A
Ann Oncol; 1992 Sep; 3 Suppl 4():35-8. PubMed ID: 1450078
[No Abstract] [Full Text] [Related]
38. Detection of immunoglobulin heavy chain gene rearrangements in classic hodgkin lymphoma using commercially available BIOMED-2 primers.
Chute DJ; Cousar JB; Mahadevan MS; Siegrist KA; Silverman LM; Stoler MH
Diagn Mol Pathol; 2008 Jun; 17(2):65-72. PubMed ID: 18382369
[TBL] [Abstract][Full Text] [Related]
39. FOXO1 is a tumor suppressor in classical Hodgkin lymphoma.
Xie L; Ushmorov A; Leithäuser F; Guan H; Steidl C; Färbinger J; Pelzer C; Vogel MJ; Maier HJ; Gascoyne RD; Möller P; Wirth T
Blood; 2012 Apr; 119(15):3503-11. PubMed ID: 22343918
[TBL] [Abstract][Full Text] [Related]
40. Gene expression profiling of microdissected Hodgkin Reed-Sternberg cells correlates with treatment outcome in classical Hodgkin lymphoma.
Steidl C; Diepstra A; Lee T; Chan FC; Farinha P; Tan K; Telenius A; Barclay L; Shah SP; Connors JM; van den Berg A; Gascoyne RD
Blood; 2012 Oct; 120(17):3530-40. PubMed ID: 22955918
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
